UP

Uttam Panwar

Director DIN 00068444
DIN 00068444 First appointment Aug 1998
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 3 historical roles
Total affiliations 3 Since Aug 1998
Shareholding value β€’β€’β€’β€’ Premium profile

About Uttam Panwar

Data last updated:

Uttam Panwar was a Director at Amend Pharma Private Limited (from 2007), Director at Encore Pharma Private Limited (from 2006) and Director at Amend Drugs Private Limited (from 1998).

DIN 00068444
First Appointment 10 Aug 1998
Oldest Company Age 28 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amend Pharma Private Limited U24230MP2007PTC019917
Director15 Oct 20072007Strike Off
Encore Pharma Private Limited U33111UP2006PTC032594
Director06 Dec 20062006Strike Off
Amend Drugs Private Limited U24232MP1998PTC012988
Director10 Aug 19981998Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Amend Pharma Private Limited
Encore Pharma Private Limited
Amend Drugs Private Limited
Premium access

Shareholding and investment profile for Uttam Panwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uttam Panwar

Uttam Panwar was first appointed on 10 Aug 1998 as Director at Amend Drugs Private Limited. The most recent appointment on record is 15 Oct 2007 at Amend Pharma Private Limited.

Uttam Panwar held 3 earlier board appointments: Amend Pharma Private Limited (Director, from 15 Oct 2007); Encore Pharma Private Limited (Director, from 06 Dec 2006); Amend Drugs Private Limited (Director, from 10 Aug 1998).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available